Participant centred trials: reducing burden as a moral obligation
Emma Law makes the case for the moral contract that should sit at the heart of every clinical trial.
The current status quo in clinical trials isn’t working. Through smarter trial design and delivery, we’re reducing the cost and complexity of large trials, while improving quality. Participants can be identified and recruited more rapidly and new treatments can be reliably evaluated, bringing huge benefits for patient care.
We built “Cantata” as a single, holistic solution to seamless trial and data management, from start to finish. Using highly-secure cloud technology, Cantata is rapidly configured to the specific requirements of each trial, reducing inefficiency and data transfer risk. Cantata is configured to meet the needs of the trial, rather than compromising the trial to fit constrictive IT.
As a not-for-profit, we work collaboratively with partners, patients, regulators and policy makers. Together, we find opportunities to use policy and regulatory tools to create a world in which trials are able to deliver the results needed to improve the lives of patients worldwide.
Emma Law makes the case for the moral contract that should sit at the heart of every clinical trial.
The award was given in recognition of outstanding services to life sciences.
Protas senior team share what they want to see change in clinical trials this year.
We’re excited to work with like-minded organisations which share our belief in the need for smarter clinical trials. Whether about designing and delivering cost-effective, higher-quality trials, our streamlined trial management technology or transforming the clinical trials ecosystem, get in touch to discuss how we could work together.